| Serial Number | 88710925 |
| Word Mark | MILLICENT CONSULTING SERVICES LLC PHARMA | BIOTECH | HEALTHCARE | RESEARCH | DATA | SOLUTIONS |
| Filing Date | Saturday, November 30, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, June 3, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the words "MILLICENT CONSULTING SERVICES LLC" written in blue font with a solid blue underline; underneath the line is the wording "PHARMA BIOTECH HEALTHCARE RESEARCH DATA SOLUTIONS" in blue font and each of those words is separated by a small vertical blue line; to the left of all the wording is a blue shaded circle with a single line white circle inside; inside of the white circle is a white double-helix design; the other color white is the drawing is not claimed as a feature of the mark and merely represents the background. |
| Indication of Colors claimed | The color(s) blue and white is/are claimed as a feature of the mark. |
| Goods and Services | Business advisory services in the field of clinical trials; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing independent review of clinical trials for business purposes |
| Disclaimer with Predetermined Text | "CONSULTING SERVICES LLC", "PHARMA", "BIOTECH", "HEALTHCARE", "RESEARCH", "DATA", AND "SOLUTIONS" |
| Goods and Services | Clinical research in the field of oncology; Clinical research in the field of hematology; Clinical research in the field of immunooncology; Clinical research in the field of cardiology; Clinical research in the field of neurology; Clinical research in the field of immunology; Clinical research in the field of virology; Clinical research in the field of hepatology; Clinical research in the field of ophthalmology; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical research; Consulting services for others in the field of design, planning, and implementation project management of biomedical research; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 5, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, May 26, 2019 |
| First Use In Commerce Date | Sunday, May 26, 2019 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 5, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, May 26, 2019 |
| First Use In Commerce Date | Sunday, May 26, 2019 |
| Party Name | Millicent Consulting Services LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Franklin Park, NJ 08823 |
| Event Date | Event Description |
| Friday, June 3, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Friday, June 3, 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, June 3, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, November 12, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 12, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, November 12, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 13, 2021 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Monday, March 29, 2021 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, September 28, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, September 28, 2020 | LETTER OF SUSPENSION E-MAILED |
| Monday, September 28, 2020 | SUSPENSION LETTER WRITTEN |
| Saturday, May 2, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Saturday, May 2, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, May 2, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, March 10, 2020 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, March 10, 2020 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, March 10, 2020 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, March 10, 2020 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Tuesday, March 3, 2020 | ASSIGNED TO EXAMINER |
| Friday, December 6, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, December 5, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Wednesday, December 4, 2019 | NEW APPLICATION ENTERED IN TRAM |